Efficacy and Safety of Cytoreductive Therapies in Patients with Essential Thrombocythaemia Aged >80 Years: An Interim Analysis of the EXELS Study

BACKGROUND: The median age of patients diagnosed with essential thrombocythaemia (ET) is 65–70 years but the management of very elderly patients (aged >80 years) with ET has not been well characterized. OBJECTIVE: This study aimed to document the treatment patterns of very elderly patients with E...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiladjian, Jean-Jacques, Besses, Carlos, Griesshammer, Martin, Gugliotta, Luigi, Harrison, Claire, Coll, Ruth, Smith, Jonathan, Birgegård, Gunnar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing AG 2012
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586170/
https://www.ncbi.nlm.nih.gov/pubmed/23184668
http://dx.doi.org/10.1007/s40261-012-0042-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586170/
https://www.ncbi.nlm.nih.gov/pubmed/23184668
http://dx.doi.org/10.1007/s40261-012-0042-0

Ejemplares similares